Decision regret worse among African American men with prostate cancer
Higher medical mistrust and concerns about masculinity likely contribute to the increased decision regret.
Related Articles
Dr. Heidenberg on whether HoLEP study data will influence technique
“I don’t think anybody, at least in our Mayo Clinic practices, is ever doing anything other than apical release HoLEPs these days,” says Daniel J.…
Personalized therapeutic approaches in ccRCC remain challenging
“As a kidney cancer community, we need to investigate these molecular subtypes prospectively in clinical trials to determine whether specific subtypes benefit from certain therapies…
Dr. Shakuri-Rad discusses the da Vinci 5 robotic system
“The da Vinci 5, or DV5, system is the next evolution of robotic surgery,” says Jaschar Shakuri-Rad, DO, FACOS.
Dr. Bradley on disseminating high-quality information on asymptomatic bacteriuria
“I think the main question is just how to disseminate this information. Obviously, there’s a huge need,” says Megan S. Bradley, MD.
FDA accepts IND application for UGN-103 in NMIBC
The IND will initiate the launch of a phase 3 study to explore the safety and efficacy of UGN-103 in patients with low-grade, intermediate-risk NMIBC.
Novel small activating RNA therapy explored in NMIBC
The study is exploring the small activating RNA therapy RAG-01 in patients with BCG-unresponsive non–muscle-invasive bladder cancer.
UTI vaccine shows efficacy, safety in men and women
“Overall, this vaccine is safe in the long term and our participants reported having fewer UTIs that were less severe,” says Bob Yang, MBBS, FRCS.
Future Directions in Prostate Cancer Treatment
Drs Smith and Helfand look ahead and provide their thoughts on future directions in the treatment of patients with prostate cancer.
CAR T cell therapy CTX130 shows safety, efficacy in ccRCC
“Our trial presents the first and the longest durable response we have seen with an allogeneic, off-the-shelf, CAR T cell therapy in the treatment of…
Dr. Xu on why biomarkers are needed for individualized treatment approaches in RCC
“Systemic therapy for RCC has changed very quickly. Every year, it’s exciting to see that we’re getting new developments, new drug approvals, and changes in…